Study identifier:D133FR00247
ClinicalTrials.gov identifier:NCT07914881
EudraCT identifier:N/A
CTIS identifier:N/A
LungScreen-NEMO: Prospective national lung cancer screening study in high-risk never-smokers
lung cancer, Thoracic Tumors
-
no
-
All
200
Observational
40 Years - 74 Years
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Oct 2026 by AstraZeneca
AstraZeneca
-
No locations available
| Arms | Assigned Interventions |
|---|---|
| High-risk never-smokers Never-smoking men aged 50 to 74 and never-smoking women aged 40 to 74 who have at least one pre-specified high-risk factor. | - |